| Title |
Volumetric MRI Markers and Predictors of Disease Activity in Early Multiple Sclerosis: A Longitudinal Cohort Study
|
|---|---|
| Published in |
PLOS ONE, November 2012
|
| DOI | 10.1371/journal.pone.0050101 |
| Pubmed ID | |
| Authors |
Tomas Kalincik, Manuela Vaneckova, Michaela Tyblova, Jan Krasensky, Zdenek Seidl, Eva Havrdova, Dana Horakova |
| Abstract |
To compare clinical and MRI parameters between patients with clinically isolated syndrome and those converting to clinically definite multiple sclerosis within 2 years, to identify volumetric MRI predictors of this conversion and to assess effect of early relapses. |
X Demographics
The data shown below were collected from the profiles of 3 X users who shared this research output. Click here to find out more about how the information was compiled.
Geographical breakdown
| Country | Count | As % |
|---|---|---|
| United Kingdom | 1 | 33% |
| Egypt | 1 | 33% |
| Unknown | 1 | 33% |
Demographic breakdown
| Type | Count | As % |
|---|---|---|
| Members of the public | 1 | 33% |
| Science communicators (journalists, bloggers, editors) | 1 | 33% |
| Practitioners (doctors, other healthcare professionals) | 1 | 33% |
Mendeley readers
The data shown below were compiled from readership statistics for 97 Mendeley readers of this research output. Click here to see the associated Mendeley record.
Geographical breakdown
| Country | Count | As % |
|---|---|---|
| Portugal | 1 | 1% |
| Germany | 1 | 1% |
| Italy | 1 | 1% |
| Brazil | 1 | 1% |
| Slovenia | 1 | 1% |
| Spain | 1 | 1% |
| United States | 1 | 1% |
| Unknown | 90 | 93% |
Demographic breakdown
| Readers by professional status | Count | As % |
|---|---|---|
| Student > Ph. D. Student | 14 | 14% |
| Researcher | 11 | 11% |
| Student > Doctoral Student | 10 | 10% |
| Student > Bachelor | 9 | 9% |
| Other | 9 | 9% |
| Other | 25 | 26% |
| Unknown | 19 | 20% |
| Readers by discipline | Count | As % |
|---|---|---|
| Medicine and Dentistry | 40 | 41% |
| Neuroscience | 14 | 14% |
| Psychology | 5 | 5% |
| Engineering | 4 | 4% |
| Pharmacology, Toxicology and Pharmaceutical Science | 3 | 3% |
| Other | 6 | 6% |
| Unknown | 25 | 26% |